Last updated 16 days ago
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants with Moderate to Severe Atopic Dermatitis
175 patients around the world
Available in Panama, Spain, Argentina, Mexico, United States
GlaxoSmithKline
4Research sites
175Patients around the world
This study is for people with
Dermatitis
Atopic dermatitis
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Sites
Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Hospital Italiano de Buenos Aires - CABA, Buenos Aires
Consultorios Médicos Dr. Isaac Scherbovsky - Mendoza
Centro Médico - Buenos Aires Skin S.A. - CABA, Buenos Aires
Recruiting
StudyAtDventure
SponsorGlaxoSmithKline
Conditions
Atopic dermatitis
Requirements
To 75 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05999799
